BRIEF-Swedish Orphan Biovitrum: positive results of phase 3 clinical study of Alprolix

* Swedish Orphan Biovitrum and Biogen Idec announced positive results of Kids B-LONG Phase 3 clinical study that evaluated safety, efficacy and pharmacokinetics of Alprolix Source text for Eikon: Further company coverage: (Gdynia Newsroom)